Fang T - Search Results

1

Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors.

Fang T, Dong Y, Zhang X, Xie K, Lin L, Wang H. Fang T, et al. Int J Pharm. 2016 Oct 15;512(1):39-48. doi: 10.1016/j.ijpharm.2016.08.036. Epub 2016 Aug 17. Int J Pharm. 2016. PMID: 27544846

2

Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo.

Xie H, Xu X, Chen J, Li L, Wang J, Fang T, Zhou L, Wang H, Zheng S. Xie H, et al. Among authors: fang t. Chem Commun (Camb). 2016 Apr 25;52(32):5601-4. doi: 10.1039/c5cc10367c. Chem Commun (Camb). 2016. PMID: 27027105

3

Precise Engineering of Prodrug Cocktails into Single Polymeric Nanoparticles for Combination Cancer Therapy: Extended and Sequentially Controllable Drug Release.

Wang H, Wu J, Xie K, Fang T, Chen C, Xie H, Zhou L, Zheng S. Wang H, et al. Among authors: fang t. ACS Appl Mater Interfaces. 2017 Mar 29;9(12):10567-10576. doi: 10.1021/acsami.7b01938. Epub 2017 Mar 15. ACS Appl Mater Interfaces. 2017. PMID: 28271714

4

Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations.

Wang H, Chen J, Xu C, Shi L, Tayier M, Zhou J, Zhang J, Wu J, Ye Z, Fang T, Han W. Wang H, et al. Among authors: fang t. Theranostics. 2017 Aug 23;7(15):3638-3652. doi: 10.7150/thno.20028. eCollection 2017. Theranostics. 2017. PMID: 29109766 Free PMC article.

5

Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin.

Fang T , Ye Z , Wu J , Wang H . Fang T , et al. Chem Commun (Camb). 2018 Aug 14;54(66):9167-9170. doi: 10.1039/c8cc03763a. Chem Commun (Camb). 2018. PMID: 30062328

6

Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.

Shu L, Ren L, Wang Y, Fang T, Ye Z, Han W, Chen C, Wang H. Shu L, et al. Among authors: fang t. Chem Commun (Camb). 2020 Mar 10;56(20):3069-3072. doi: 10.1039/c9cc09016a. Chem Commun (Camb). 2020. PMID: 32049075

7

Supramolecular nanoparticles self-assembled from reduction-responsive cabazitaxel prodrugs for effective cancer therapy.

Jin J , Wan J , Hu X , Fang T , Ye Z , Wang H . Jin J , et al. Among authors: fang t. Chem Commun (Camb). 2021 Mar 4;57(18):2261-2264. doi: 10.1039/d0cc06854c. Epub 2021 Feb 3. Chem Commun (Camb). 2021. PMID: 33532809

8

Repurposing of camptothecin: An esterase-activatable prodrug delivered by a self-emulsifying formulation that improves efficacy in colorectal cancer.

Fang T, Ye Z, Chen X, Wang Y, Wan J, Wang H. Fang T, et al. Int J Pharm. 2021 Apr 15;599:120399. doi: 10.1016/j.ijpharm.2021.120399. Epub 2021 Feb 26. Int J Pharm. 2021. PMID: 33647408

9

Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through α ₂-AR/HIF-1α/VEGFA Pathway.

Fang T, Lin L, Ye ZJ, Fang L, Shi S, Yu KD, Miao HH, Li TZ. Fang T, et al. Among authors: fang l. Biomed Environ Sci. 2022 Oct 20;35(10):931-942. doi: 10.3967/bes2022.120. Biomed Environ Sci. 2022. PMID: 36443270 Free article.

10

Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Fang T, Cui M, Sun J, Ge C, Zhao F, Zhang L, Tian H, Zhang L, Chen T, Jiang G, Xie H, Cui Y, Yao M, Li H, Li J. Fang T, et al. Oncotarget. 2015 Jun 30;6(18):16106-19. doi: 10.18632/oncotarget.3867. Oncotarget. 2015. PMID: 25965830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,317 results

Search Page

Filters